Skip to main content

Table 2 Tumor characteristics of patients with pulmonary sclerosing pneumocytoma

From: Pulmonary sclerosing pneumocytoma and mortality risk

Characteristics

PSP surgery group

(N = 80)

PSP non-surgery group

(N = 27)

Total

(N = 107)

P

Initial department

 

0.001

Pulmonology

43 (53.8)

25 (92.6)

68 (63.6)

 

Thoracic Surgery

37 (46.2)

2 (7.4)

39 (36.4)

 

Symptom

   

0.617

No symptom

60 (75.0)

25 (92.6)

85 (79.4)

 

Cough

9 (11.2)

1 (3.7)

10 (9.3)

 

Hemoptysis

3 (3.8)

0 (0.0)

3 (2.8)

 

Chest discomfort/pain

5 (6.2)

1 (3.7)

6 (5.6)

 

Sputum

5 (6.2)

0 (0.0)

5 (4.7)

 

Dyspnea

4 (5.0)

0 (0.0)

4 (3.7)

 

Fever

1 (1.2)

0 (0.0)

1 (0.9)

 

Tumor size (cm)

2.0 (1.3–2.0)

1.7 (1.5–2.3)

1.9 (1.5–2.5)

0.541

Tumor size

   

0.334

< 1 cm

6 (7.5)

0 (0.0)

6 (5.6)

 

1–2 cm

37 (46.2)

16 (59.3)

53 (49.5)

 

2–3 cm

24 (30.0)

9 (33.3)

33 (30.8)

 

3–4 cm

12 (15.0)

1 (3.7)

13 (12.1)

 

4–5 cm

3 (3.8)

0 (0.0)

3 (2.8)

 

≥ 5 cm

2 (2.5)

1 (3.7)

3 (2.8)

 

Tumor location

   

0.405

Right upper lobe

6 (7.5)

4 (14.8)

10 (9.3)

 

Right middle lobe

19 (23.8)

8 (29.6)

27 (25.2)

 

Right lower lobe

15 (18.8)

7 (25.9)

22 (20.6)

 

Left upper lobe

15 (18.8)

3 (11.1)

18 (16.8)

 

Left lower lobe

27 (33.8)

5 (18.5)

32 (29.9)

 

Tumor Number

   

0.570

Single

76 (95.0)

27 (100.0)

103 (96.3)

 

Two

4 (5.0)

0 (0.0)

4 (3.7)

 

Initial diagnostic methods

 

<  0.001

Percutaneous needle biopsy

24 (30.0)

27 (100.0)

51 (47.7)

 

Surgery

53 (66.2)

0 (0.0)

53 (49.5)

 

Bronchoscopic biopsya

3 (3.7)

0 (0.0)

3 (2.8)

 

Surgery methods (only for surgery group)

  

Pneumonectomy

0 (0.0)

   

Lobectomy

24 (30.0)

   

Segmentectomy

12 (15.0)

   

Wedge resection

44 (55.0)

   

Enucleation

1 (1.2)

   

Lymph node enlargement on CT

6 (7.5)

1 (3.7)

7 (6.5)

0.676

Lymph node dissection during surgery

(only for surgery group)

38 (47.5)

   

Lymph node metastasis (only for surgery group)

0 (0.0)

   

Distant metastasis

0 (0.0)

0 (0.0)

0 (0.0)

 

Recurrence

0 (0.0)

0 (0.0)

0 (0.0)

 
  1. Continuous variables are expressed as median (interquartile range)
  2. Categorical variables are expressed as number (%)
  3. CT Computed tomography
  4. a Two of them were diagnosed with endobronchial ultrasound guided-transbronchial needle aspiration for lung nodules, not lymph nodes